|
US 12,268,731 B2 |
|
| Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG) |
| Bai Liu, Culver City, CA (US); Peter Rhode, Culver City, CA (US); Wenxin Xu, Culver City, CA (US); and Hing C. Wong, Culver City, CA (US) |
| Assigned to Altor Bioscience, LLC, Culver City, CA (US) |
| Filed by Altor Bioscience, LLC, Culver City, CA (US) |
| Filed on Apr. 18, 2024, as Appl. No. 18/639,678. |
| Application 18/063,871 is a division of application No. 17/825,959, filed on May 26, 2022, granted, now 11,679,144, issued on Jun. 20, 2023. |
| Application 15/921,512 is a division of application No. 14/755,989, filed on Jun. 30, 2015, granted, now 9,925,247, issued on Mar. 27, 2018. |
| Application 18/639,678 is a continuation of application No. 18/394,409, filed on Dec. 22, 2023. |
| Application 18/394,409 is a continuation of application No. 18/063,871, filed on Dec. 9, 2022, granted, now 11,890,323, issued on Feb. 6, 2024. |
| Application 17/825,959 is a continuation of application No. 16/925,138, filed on Jul. 9, 2020, granted, now 11,471,511, issued on Oct. 18, 2022. |
| Application 16/925,138 is a continuation of application No. 16/444,807, filed on Jun. 18, 2019, granted, now 11,173,191, issued on Nov. 16, 2021. |
| Application 16/444,807 is a continuation of application No. 15/921,512, filed on Mar. 14, 2018, granted, now 10,537,615, issued on Jan. 21, 2020. |
| Claims priority of provisional application 62/018,899, filed on Jun. 30, 2014. |
| Prior Publication US 2024/0252591 A1, Aug. 1, 2024 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. A61K 38/20 (2006.01); A61K 38/17 (2006.01); A61K 39/07 (2006.01); A61K 47/64 (2017.01); A61P 35/00 (2006.01); A61K 39/04 (2006.01); C07K 14/35 (2006.01); C07K 14/54 (2006.01); C07K 14/715 (2006.01); C07K 16/28 (2006.01) |
